ADIPOQ and metabolic dysfunction-associated steatotic liver disease: Several examples are as follows: adiponectin treatment decreases the lipid accumulation in human macrophage cells [28], adiponectin regulates energy homeostasis through AMPK-ACC pathway [29], and adiponectin concentration in serum is lower in obese persons and patients with type 2 diabetes mellitus and NAFLD [30].